{"id":"NCT05827978","sponsor":"ModernaTX, Inc.","briefTitle":"Study of mRNA-1010 Seasonal Influenza Vaccine in Adults","officialTitle":"A Phase 3, Randomized, Stratified, Observer-Blind, Active-Controlled Study to Evaluate the Immunogenicity, Reactogenicity and Safety of mRNA-1010 Seasonal Influenza Vaccine in Adults 18 Years and Older","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2023-04-17","primaryCompletion":"2024-06-24","completion":"2024-06-24","firstPosted":"2023-04-25","resultsPosted":"2025-07-10","lastUpdate":"2025-07-10"},"enrollment":8411,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Seasonal Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"mRNA-1010","otherNames":["Seasonal influenza vaccine"]},{"type":"BIOLOGICAL","name":"Licensed Quadrivalent Inactivated Seasonal Influenza Vaccine","otherNames":["Fluarix Quadrivalent","Fluzone HD"]}],"arms":[{"label":"mRNA-1010","type":"EXPERIMENTAL"},{"label":"Licensed Quadrivalent Inactivated Seasonal Influenza Vaccine","type":"ACTIVE_COMPARATOR"}],"summary":"This study includes 3 parts: Parts A, B, and C. The purpose of this study is to evaluate the immunogenicity and safety of mRNA-1010 seasonal influenza vaccine in adults.","primaryOutcome":{"measure":"Geometric Mean Titer (GMT) of Anti-Hemagglutinin (HA) Antibody Levels as Measured by Hemagglutination Inhibition (HAI)","timeFrame":"Day 29","effectByArm":[{"arm":"Part A: Fluarix QIV","deltaMin":147.49,"sd":null},{"arm":"Part A: mRNA-1010","deltaMin":220.17,"sd":null},{"arm":"Part B: Fluarix QIV","deltaMin":137.9,"sd":null},{"arm":"Part B: mRNA-1010","deltaMin":208.1,"sd":null},{"arm":"Part C: Fluzone HD QIV","deltaMin":130.09,"sd":null},{"arm":"Part C: mRNA-1010","deltaMin":174.81,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":12},"locations":{"siteCount":103,"countries":["United States"]},"refs":{"pmids":["39919447"],"seeAlso":["https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217501&amp;parentIdentifier=mRNA-1010-P303&amp;attachmentIdentifier=9b318591-af2c-4469-afb9-4a18e6eeb09e&amp;fileName=1010-P303_Temp-0080_Protocol_Template_for_Registrations_19Jan23.docx&amp;versionIdentifier="]},"adverseEventsSummary":{"seriousAny":{"events":21,"n":1180},"commonTop":[]}}